focus -WSS

focus

author：Wikipedia 2025-10-01 21:09:11 - browse：1396

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： CDC: Uninsured rate hit 'record low' right as states cut Medicaid

WSS

Death of patient in Alzheimer’s trial raises question of possible risks

My superpower is killing ticks

Biden calls for immediate release of Niger's president amid apparent coup

What would happen to your eyes if you looked at the solar eclipse?

Weight bias in eating disorder treatment complicated by new weight loss drugs

Why are elite athletes different? Take a look at their microbes

hotspot

focus

entertainment

In age of alternative facts, a scholarly course on calling out crap

The story of mRNA: From a loose idea to a tool that may help curb Covid

Medicare proposal to cover medical devices draws a mixed reaction

Death of patient in Alzheimer’s trial raises question of possible risks

ChatGPT in medicine: STAT answers readers' burning questions

My superpower is killing ticks

Medical records are filled with copy

Verily hires former Apple Health leader as chief scientific officer

Jerome Adams on the need for new antivirals for Covid

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

leisure time

Why we need to separate burnout from moral injury in health care

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Biden calls for immediate release of Niger's president amid apparent coup

Cloning humans is technically possible. It's curious no one has tried

WATCH: Why do fingernails fall off when they're damaged?

focus

leisure time

hotspot

leisure time